{"Q": 1, "answer": "no", "rationale": "The segment discusses manufacturing capacity but does not contain an intensifier or comparative modifying a risk-adjective.", "method": "llm_batch", "batch_id": "batch_1_17028", "batch_size": 200, "batch_pos": 103, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 2, "answer": "no", "rationale": "The segment does not contain high-potency verbs, potent metaphors, or other Q2 Alarmist cues.", "method": "llm_batch", "batch_id": "batch_2_16736", "batch_size": 200, "batch_pos": 67, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 3, "answer": "no", "rationale": "The segment contains 'is' and 'tell' and 'will be able to manufacture' and 'said' which are not moderate verbs from the list.", "method": "llm_batch", "batch_id": "batch_3_13608", "batch_size": 200, "batch_pos": 200, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 4, "answer": "no", "rationale": "The segment does not contain a loaded rhetorical question.", "method": "llm_batch", "batch_id": "batch_4_11304", "batch_size": 200, "batch_pos": 187, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 5, "answer": "no", "rationale": "Reports factual limitation without explicit calming language.", "method": "llm_batch", "batch_id": "batch_5_19228", "batch_size": 200, "batch_pos": 183, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 6, "answer": "no", "rationale": "The segment does not contain a minimiser combined with a scale contrast.", "method": "llm_batch", "batch_id": "batch_6_7708", "batch_size": 200, "batch_pos": 121, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 7, "answer": "no", "rationale": "Segment contains 'too early to tell' which is about knowledge status, not a Q7 bare negation.", "method": "llm_batch", "batch_id": "batch_7_20536", "batch_size": 200, "batch_pos": 110, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 8, "answer": "no", "rationale": "The segment describes a limitation/uncertainty in manufacturing capability, not the capability itself.", "method": "llm_batch", "batch_id": "batch_8_17584", "batch_size": 200, "batch_pos": 74, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 9, "answer": "no", "rationale": "The segment discusses manufacturing capacity/timing rather than factual reporting of prices or economic metrics.", "method": "llm_batch", "batch_id": "batch_9_18104", "batch_size": 200, "batch_pos": 185, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 10, "answer": "no", "rationale": "The segment discusses future manufacturing capability, not future relief from the threat.", "method": "llm_batch", "batch_id": "batch_10_16860", "batch_size": 200, "batch_pos": 7, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 11, "answer": "no", "rationale": "Quote from Robert Johnson is a factual statement about manufacturing uncertainty. No explicit alarm or reassurance.", "method": "llm_batch", "batch_id": "batch_11_16464", "batch_size": 200, "batch_pos": 185, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
{"Q": 12, "answer": "yes", "rationale": "Factual statement about manufacturing uncertainty without explicit framing cues.", "method": "llm_batch", "batch_id": "batch_12_17796", "batch_size": 200, "batch_pos": 185, "statement_text": "It is too early to tell how many doses Moderna will be able to manufacture, said Robert Johnson, director of the medical countermeasures program at HHS, on the call.", "article_id": 1745}
